Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Buying Ulta Stock Is a Timing Gamble

By Chris Markoch, InvestorPlace Contributor

If the economy bounces back to normal after the coronavirus fades, Ulta stock today represents a great discount. However, this is a huge assumption to make.

GE Stock Needs More Than Wishful Thinking to Stay Alive

By Chris Markoch, InvestorPlace Contributor

Even without the pandemic, GE stock was a challenging bet on an unlikely recovery. But given the economic damage, it's hard to have much hope for General Electric.

Have Investors Missed the Rally for XOM Stock?

By Chris Markoch, InvestorPlace Contributor

XOM stock may be a quality dividend play on a great discount. However, you should also be prepared for some choppy waters ahead.

3 Healthcare Stocks to Buy for AI and Big Data

By Chris Markoch, InvestorPlace Contributor

Healthcare stocks are in the spotlight as the coronavirus brings to light the importance of collecting data and using it to predict outcomes.

DPZ Stock Has Become a Timely Defensive Stock

By Chris Markoch, InvestorPlace Contributor

The pizza chain is delivering food to shut-in Americans and jobs to displaced workers, making DPZ stock a viable, "feel-good" investment.

The Coronavirus Is the Latest Obstacle for CGC Stock

By Chris Markoch, InvestorPlace Contributor

The cannabis industry faced significant challenges before the coronavirus erupted. But with the pandemic bringing everything to a halt, CGC stock is simply not worth the risk.

Will Candor Be Enough to Save JBLU Stock?

By Chris Markoch, InvestorPlace Contributor

JetBlue's transparency amid the crisis is admirable. However, transparency alone won't bring back sentiment for JBLU stock.

Lifeboats Will Come to Rescue Carnival Stock

By Chris Markoch, InvestorPlace Contributor

Carnival's revenues and CCL stock are sure to keep sinking as the coronavirus spreads. But lifeboats should come to its rescue in late 2020.

Coronavirus Fears Won’t Eliminate Qualcomm Stock’s 5G Catalyst

By Chris Markoch, InvestorPlace Contributor

Qualcomm stock is being battered along with the entire semiconductor sector. However, the 5G catalyst for Qualcomm remains in place.

3 Networking Stocks That Are Helping the World Telecommute

By Chris Markoch, InvestorPlace Contributor

Networking stocks are on the rise, as employees are forced to work from home. Here are three names that should thrive even after the crisis.

Load More